Document is current

Any future updates will be listed below

Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the “all-around warrior” in immunotherapy

Crossref DOI link: https://doi.org/10.1186/s12943-024-02121-9

Published Online: 2024-09-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark